Jupiter Neurosciences is a B2i Digital Featured Company. See the company’s profile at At BIO, Jupiter will discuss its FDA-cleared Phase IIa clinical program in Parkinson’s disease. In November 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results